Full-Time

Program Specialist

Confirmed live in the last 24 hours

American Academy of Family Physicians

American Academy of Family Physicians

501-1,000 employees

Professional organization for family physicians

No salary listed

Junior, Mid

Leawood, KS, USA

Hybrid position; possible 6-10 days travel annually.

Category
Generalist Operations
Operations & Logistics
Required Skills
Public Speaking
Requirements
  • Bachelor’s degree or knowledge acquired through equivalent work experience
  • At least two years of relevant experience (or recent graduates with demonstrated excellence)
  • Demonstrated excellence in organizational, communication, and critical thinking skills
  • Basic accounting knowledge and a strong aptitude for math
  • Public speaking and report writing skills
  • Ability to take meeting minutes and manage programs
  • Comfortable collaborating with people in a variety of settings and staffing levels
  • Basic computer skills with knowledge using Microsoft products
Responsibilities
  • Manage every aspect of the Family Medicine Chapter Alliance (FMCA)
  • Administer all aspects of the FMCA Grant Awards, Chapter Engagement Grants, and Outstanding Program Award
  • Work closely with marketing and the Steering Committee to support promotion and program development
  • Serve as a liaison between the AAFP Foundation and DARTNet Institute in the management of the Family Medicine Discovers program
  • Represent the Foundation at Work Group and internal meetings
  • Manage/administer the Student Externship Matching Grant Program (SEMG)
  • Develop and implement new strategies to support program growth
  • Perform other duties as assigned, such as donor thank you notes and managing the Family Physician Assistance program
American Academy of Family Physicians

American Academy of Family Physicians

View

The American Academy of Family Physicians (AAFP) focuses on supporting family physicians and promoting the specialty of family medicine. It offers a variety of resources including continuing medical education (CME) courses, journals, and practice management tools to help physicians stay updated on medical practices and improve patient care. AAFP's products, such as mobile applications and self-study packages, assist physicians in managing their practices and enhancing their medical knowledge. Unlike other medical organizations, AAFP emphasizes the unique role of family medicine and advocates for policies that benefit family physicians and their patients. The goal of AAFP is to advance the practice of family medicine and ensure that family physicians have the resources they need to provide high-quality care.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Leawood, Kansas

Founded

1947

Simplify Jobs

Simplify's Take

What believers are saying

  • Telemedicine adoption enhances patient care accessibility for family physicians.
  • Rising demand for CME indicates a growing need for educational resources.
  • Wearable health technology offers new data sources for patient management.

What critics are saying

  • AI preference may reduce demand for traditional family physicians.
  • Intense competition in wound management may shift focus from family medicine.
  • New health products may impact traditional family medicine practices.

What makes American Academy of Family Physicians unique

  • AAFP offers a comprehensive range of CME courses for family physicians.
  • AAFP provides resources for ICD-10 CM updates, aiding in accurate medical coding.
  • AAFP collaborates with affiliates to advance family medicine specialty.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

PR Newswire
Jun 9th, 2025
Verb Products Launches Clinically Proven Density Peptide Collection To Combat Hair Thinning And Shedding

NEW YORK, June 9, 2025 /PRNewswire/ -- VERB Products, the destination for salon-quality haircare at one set affordable price, announces the launch of its latest innovation: the Density Peptide Collection, a two-step system scientifically developed to target thinning hair and visible signs of shedding

Forbes
May 23rd, 2025
Make America Tan Again: “Big, Beautiful Bill” Burns The Tanning Tax

After Obamacare slapped a 10% tax on tanning bed services, Nicole "Snooki" Polizzi launched her Sunless Tanning Collection. (She's shown here at a 2012 launch event.) Spray-on tans are exempt from the tax, which Republicans now want to repeal. Ed Rode/Getty Images). Tucked among the trillions of tax cuts in the House’s just-passed “big, beautiful bill” is the repeal of the tax on indoor tanning services. But before you rush to book a tanning bed appointment, remember that the Senate still has to act on this bill and that dermatologists are no fans of tanning. About The Tax

PR Newswire
Mar 29th, 2025
Ozempic® (Semaglutide) Injection 1 Mg Showed Improved Functional Outcomes And Health-Related Quality Of Life In Phase 3 Stride Trial In Adults With Type 2 Diabetes And Peripheral Artery Disease (Pad) Presented At Acc 2025

Semaglutide 1 mg demonstrated statistically significant and superior improvement in maximum walking distance by 13% over placebo in adults with type 2 diabetes and symptomatic PAD 1Based on STRIDE trial data, presented at the American College of Cardiology's (ACC) Annual Scientific Session and Expo while simultaneously published today in The Lancet , Novo Nordisk submitted a label extension application accepted for review by the FDAApproximately 12 million people in the United States are impacted by PAD, a form of atherosclerotic disease, and one in four also have type 2 diabetes2,3PLAINSBORO, N.J., March 29, 2025 /PRNewswire/ -- Novo Nordisk today presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic® (semaglutide) injection 1 mg in adults with type 2 diabetes and early-stage symptomatic PAD1, at the American College of Cardiology's (ACC) Annual Scientific Session and Expo. The results were presented during a late-breaking clinical trial session and highlighted at an official ACC press conference. In addition, the analysis was also simultaneously published today in The Lancet.The double-blind, randomized, placebo-controlled STRIDE trial, which enrolled 792 adults with type 2 diabetes and symptomatic PAD, achieved its primary endpoint, with semaglutide 1 mg demonstrating a 13% superior improvement in maximum walking distance (estimated treatment ratio [ETR] vs placebo, 1.13; 95% confidence interval [CI], 1.06 to 1.21; p=0.0004) and a clinically meaningful median treatment difference of 26.4 meters (95% CI, 11.8 to 40.9; approximately 87 feet, or about a third the length of an American football field) on a 12% incline, compared to placebo at 52 weeks. The trial also demonstrated superiority to placebo for all confirmatory secondary outcomes assessed, including pain-free walking distance (ETR vs placebo 1.11; 95% CI, 1.03 to 1.20; p=0.0046) and Vascular Quality of Life Questionnaire-6 (VascuQoL-6) (estimated treatment difference vs placebo 1.00; 95% CI, 0.48 to 1.52; p=0.011) at 52 weeks.1,4"Peripheral artery disease (PAD) may cause severe symptoms, physical limitations, and a diminished quality of life, often making even short walks—such as retrieving the mail—challenging. In individuals with PAD and diabetes, the disease can be even more severe, affecting small blood vessels and limiting the effectiveness of revascularization procedures and other treatments. Semaglutide 1 mg is the first medication in over two decades to show meaningful improvements in functional capacity and quality of life, which could address a critical unmet need for those with both PAD and type 2 diabetes," said Marc P

PR Newswire
Jan 27th, 2025
Intense Competition In The U.S. Wound And Tissue Management Market Driving Innovation

VANCOUVER, BC, Jan. 27, 2025 /PRNewswire/ - The U.S. wound and tissue management market is a highly competitive industry with multiple competing segments positioned as substitutes for one another. This intense competition will limit market growth despite the otherwise strong presence of major drivers of growth including demographic factors, rising rates of diabetes, obesity, and favorable Medicare policies. Competition is further driven by a constant need to innovate to avoid the commoditization of products within the market which would lead to price competition and slim profit margins. The US market for wound and tissue management is expected to grow to reach nearly $16 billion USD by 2030

WAFP
Jan 10th, 2025
Nominations Being Accepted for AAFP Board

Submissions will be reviewed by the AAFP Nominating Committee, which was established at the 2023 Congress of Delegates.